Global Hematology Diagnostic Devices And Equipment Market Outlook 2024, Forecast To 2033
12 Jan, 2024
The hematology diagnostic devices and equipment market size has demonstrated rapid growth, rising from $2.15 billion in 2023 to $2.41 billion in 2024, with an 11.8% CAGR. Historical growth is attributed to clinical diagnostics, blood banking, oncology and hematological disorders, and monitoring disease progression. Anticipating rapid growth, the market is projected to reach $3.7 billion in 2028, showcasing an 11.4% CAGR. Future growth drivers include an aging population, personalized medicine, rising blood-related disorders, and hematological biomarkers. Key trends encompass technological advancements, point-of-care hematology testing, automation and integration, and telemedicine and remote monitoring.
Global Hematology Diagnostic Devices And Equipment Market Key Driver
Hematology diagnostic devices gain prominence due to the increasing prevalence of blood disorders affecting millions worldwide. The devices, crucial for identifying blood disorders, address issues impacting blood cell counts, with a significant impact on global health.
Get A Free Sample Of The Global Hematology Diagnostic Devices And Equipment Market ReportGlobal Hematology Diagnostic Devices And Equipment Market Segments
The hematology diagnostic devices and equipment market covered in this report is segmented –
1)By Product: Instruments, Consumables
2)By Instruments: Analyzers, Flow cytometers, Other Instruments
3)By Consumables: Reagents, Stains, Other Consumables
4)By Application: Drug Testing, Auto-Immune Disease, Cancer, Diabetes Mellitus, Infectious Disease, Other Applications
5)By End User: Hospitals, Specialized Diagnostic Centers, Specialized Research Institutes
By Geography: The regions covered in the hematology diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions
North America was the largest region in the global hematology diagnostics devices and equipment market in 2023. Asia-Pacific was the second-largest region in the hematology diagnostics devices and equipment market. The regions covered in the hematology diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Major Hematology Diagnostic Devices And Equipment Industry Players
Abbott Diagnostics, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Drucker Diagnostics Inc., Horiba Ltd., Instrumentation Laboratory Inc., Siemens Healthcare, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., F.Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., HemoCue AB, Mindray Medical International Limited, NORMA Group, Danaher Corporation, Edan Instruments Inc., Novo Nordisk, Sysmex Corporation, Fluidigm Corporation, CellaVision, Maccura Biotechnology Co., DY mind Biotech, Balio Diagnostics, BioSystems Diagnostics Pvt. Ltd., Wiener Lab, Accurex Biomedical Pvt. Ltd., ARKRAY USA, Boule Diagnostics AB, DermaFlow, Diagnostics Holdings, Diatron Group, EKF Diagnostics Holdings, Grifols, S.A., ICU Medical Inc., Nihon Kohden Corporation, Ortho Clinical Diagnostics, PixCell Medical, STRATEC Biomedical AG, Terumo BCT, Z-Medica Corporation
Get The Full Global Hematology Diagnostic Devices And Equipment Market Report
Hematology Diagnostic Devices And Equipment Market Overview
Hematology diagnostic devices and equipment are used to diagnose diseases related to blood, vascular systems, bone marrow, autoimmune disorders, and hemostasis.
Hematology Diagnostic Devices And Equipment Global Market Report 2023 provides data on the global hematology diagnostic devices and equipment market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The hematology diagnostic devices and equipment market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.